Advertisement
News
Subscribe to MDT Magazine News

Amgen completes acquisition of BioVex Group

March 4, 2011 12:45 pm | by The Associated Press | Comments

Biotechnology company Amgen Inc. said Friday it has completed the acquisition of cancer therapy developer BioVex Group.BioVex is developing a cancer treatment called OncoVex, a virus aimed at attacking cancer cells, destroying tumors and stimulating the immune system to fight cancer throughout...

Vaccinated children not at higher risk of infections or allergic diseases

March 4, 2011 12:36 pm | by EurekAlert | Comments

(Deutsches Aerzteblatt International) May vaccinations put too much strain on or weaken children's immune systems and are therefore harmful? Roma Schmitz and her colleagues from the Robert Koch Institute investigate exactly this research question in the current issue of Deutsches...

TOPICS:

Don't miss March 7 pre-registration deadline for Valencia meetings

March 4, 2011 12:35 pm | by EurekAlert | Comments

(International Osteoporosis Foundation) March 7 is the pre-registration deadline for the most important European bone meetings of the year, to be held in Valencia, Spain. The European Congress on Osteoporosis & Osteoarthritis will be held in Valencia's award-winning congress center...

TOPICS:
Advertisement

Agribusiness giant ADM strikes 20-year licensing deal with Burcon NutraScience

March 4, 2011 11:45 am | by The Associated Press | Comments

One of the world's biggest agribusinesses, Archer Daniels Midland, has licensed the rights to a Canadian company's soy product for making protein-fortified beverages such as juices, soft drinks and sports drinks. Burcon NutraScience Corp. (TSX:BU) says it will receive royalty payments on ADM's...

Site-wide License for Ariadne's Pathway Studio Renewed by NCI

March 4, 2011 10:34 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., March 4, 2011 /- Ariadne , a leader in bioinformatics software and knowledge integration, announced that National Cancer Institute (NCI) has renewed their license for Pathway Studio ® Enterprise system that includes the ResNet® Mammalian database and Ariadne...

TOPICS:

Select Medical 4Q profit slides 30 pct

March 4, 2011 9:45 am | by The Associated Press | Comments

Select Medical Holdings Corp. said its fourth-quarter profit dropped 30 percent due to the acquisition of Regency Hospital Co. and higher expenses.The Mechanicsburg, Pa., company said Thursday after markets closed that it earned $20.9 million, or 13 cents per share, in the three months that...

Blue Sky Biotech infused with Ampersand VC backing

March 4, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Blue Sky Biotech Inc., a Worcester-based contract research organization for the pharmaceutical industry, has taken an investment from private equity firm Ampersand Ventures of Wellesley.

TOPICS:

Medical video firm Image Stream raises $2M

March 4, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Image Stream Medical Inc., a Littleton developer of video technology for hospital operating rooms, has raised $2 million in an equity offering, according to a regulatory filing.

Advertisement

Beaumont First in State to Perform Robotic Heart Procedure for Atrial Fibrillation

March 4, 2011 8:33 am | by Bio-Medicine.Org | Comments

ROYAL OAK, Mich., March 4, 2011 /- Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery....

TOPICS:

Sigma-Aldrich to Present at Upcoming Investor Conferences

March 4, 2011 8:33 am | by Bio-Medicine.Org | Comments

ST. LOUIS, March 4, 2011 /- Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the following investor conferences in March: 31st Annual Cowen and Company Healthcare Conference on Tuesday, March 8, 2011, at the Boston Marriot Copley Place, Boston, MA, presenting at 10:15 AM...

TOPICS:

Talecris, Grifols delay closing of $3.4B deal

March 4, 2011 7:45 am | by The Associated Press | Comments

Talecris Biotherapeutics Holdings Corp. said Friday the closing of its sale to Spanish health care company Grifols SA is being delayed by almost three months.Grifols agreed to buy Talecris in June for $3.4 billion, or $26.16 per share in cash and stock. The companies had said they expected the...

Epizyme moving HQ to Vassar Street

March 4, 2011 7:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge biotech Epizyme Inc. plans to move its headquarters from Memorial Drive to 325 Vassar Street, doubling its space.

Topamax (topiramate): Label Change - Risk For Development of Cleft Lip and/or Cleft Palate in Newborns

March 4, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

Increased risk of oral clefts in infants born to women treated with Topamax (topiramate) during pregnancy.

TOPICS:

Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map

March 4, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., March 4, 2011 /- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs. Facing an ever-changing launch landscape,...

TOPICS:

ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology

March 4, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHICAGO, March 4, 2011 /- The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading